Georgia CTSA Newsletter
|
Trouble viewing this email? View on the web.
| |
|  | 
Georgia CTSA
Weekly eRoundup
May 1, 2020
|
| |
| | | | | "The Georgia Clinical and Translational Science Alliance (Georgia CTSA) Clinical Research Center (GCRC) sites welcome clinical investigators from all academic levels and disciplines. We stand ready to facilitate the use of our resources for pilot projects, single-center and multicenter trials, and other clinical research, including industry, foundation, and federally-funded research," says Thomas Ziegler, MD.
May 1, 2020, marks the 60th anniversary ... | | | | Read More | | |
|
| |
| | | | | | Calling All Mentees: The Georgia Clinical and Translational Science Alliance TEAMS (Translational Education and Mentoring in Science) Program is seeking junior-level faculty members, post-docs, or clinical fellows interested in receiving 1:1 and group mentoring. Apply now to be a Fellow! | | | | Apply Now! | | |
|
| |
| | | | Latrice Rollins, PhD, MSW, (Georgia CTSA Evaluation and Continuous Improvement and Community Engagement Programs; Morehouse School of Medicine) and Darrell Sabbs (Georgia CTSA Community Engagement Program Community Steering Board) spoke to the Washington Post about the opportunities for fathers to be a resource in improved health outcomes for their sons. We are proud to have them among us making national news! | | | | Read More | | |
| |
| | | | The NIH Common Fund received $30 Million from the Coronavirus Aid, Relief, and Economic Security (CARES) Act, 2020 to prevent, prepare for, and respond to coronavirus, domestically or internationally. OSC issued this Notice of Special Interest (NOSI), an opportunity for emergency competitive revisions to Common Fund grants and cooperative agreements to support innovative, impactful research on COVID-19 or SARS-CoV-2 in any area of research including behavioral/social science, health disparities, and novel therapeutics that fits within the mission of an emergency response to provide critical expertise, resources or activities. OSC plans to use a portion of the CARES Act funds to support 10-20 high-impact, one-year, one-time, competitive revisions for Common Fund awards only in Fiscal year 2020. OSC is planning new funding opportunities to support new research projects in these areas beginning in Fiscal Year 2021. OSC staff will host a technical assistance webinar to answer applicant questions on May 6, 2020. Applications will be accepted on a rolling basis from April 15, 2020 through June 19, 2020, by 5:00 PM local time of the applicant organization. | | | | Read More | | |
| |
| | | | If you are a scientist at an academic institution currently working on a COVID-19 related project and in need of funding, we invite you to apply for a Fast Grant. Fast Grants are $10k to $500k and decisions are made in under 48 hours. If we approve the grant, you'll receive payment as quickly as your university can receive it. | | | | Read More | | |
| |
| | | | As the COVID-19 situation continues to develop, it’s critically important that researchers, who are learning about the virus and pursuing science-based solutions to the global coronavirus pandemic, can find the funding they need. With this in mind, GrantForward is proud to provide free access to a list of funding opportunities in the area of COVID-19. The list of available coronavirus-related funding calls and other support for researchers, non-profit organizations and commercial organizations, with all relevant information, will be updated on a daily basis. | | | | Read More | | |
| |
| | | | NIH and CDC notify PD(s)/PI(s) holding specific types of research grants that funds are available for administrative supplements to enhance the diversity of the research workforce by recruiting and supporting students, postdoctorates, and eligible investigators from underrepresented backgrounds, including those from groups that have been shown to be nationally underrepresented in health-related research. This supplement opportunity is also available to PD(s)/PI(s) of research grants who are or become disabled and need additional support to accommodate their disability in order to continue to work on the research project. This FOA is designed specifically for applicants proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary clinical trial. Applicants to this FOA are permitted to propose research experience in a clinical trial led by a mentor or co-mentor. Interested applicants should contact Andrew West at awest2@emory.edu. | | | | Read More | | |
| |
| | | | With information and funding opportunities quickly evolving during this pandemic, we want to make sure our NCATS Consortium has the most up-to-date and readily available information. You can find the latest opportunities that NCATS is participating in, by following this link below. | | | | Read More | | |
| |
| | | | The NIH is devoting significant resources to COVID-19. In addition to dedicating regularly appropriated funds, to date NIH has received emergency funding for COVID-19-related activities in two supplemental bills. To get funding as quickly as possible to the research community, we are using Urgent and Emergency competing revisions and administrative supplements to existing grant awards. Learn more about what is available today. | | | | Read More | | |
| |
| | | | For up-to-date NIH COVID-19 information, including: Informational Videos; Proposal Submission & Award Management Resources; Human Subjects & Clinical Trials Guidance; Animal Welfare; Frequently Asked Questions regarding flexibilities for grantees and; Funding Opportunities, please visit the link below. | | | | Read More | | |
| |
| | | | The COVID-19 global emergency raises many difficult questions, such as: who is infectious, who may need hospital care and at what level, what are the key risk factors, and more. To address these and many other questions, the National Center for Data to Health and NCATS are leading the creation of a national, centralized, secure portal for COVID-19 clinical data. The cloud-based collaborative portal will allow for the development of machine learning and other informatics tools that require a large row-level dataset and will be overseen by a data access committee. We believe this portal will provide additional assets needed to rapidly develop the analytics that clinical centers and physicians need now. | | | | Read More | | |
| |
| | | | Robert Wood Johnson Foundation seeks proposals that are primed to influence health equity in the future. We are interested in ideas that address any of these four areas of focus: Future of Evidence; Future of Social Interaction; Future of Food; Future of Work. Additionally, we welcome ideas that might fall outside of these four focus areas, but which offer unique approaches to advancing health equity and our progress toward a Culture of Health. | | | | Read More | | |
| |
| | | | Schools, public libraries, and nonprofit organizations who help students that are below grade level or having trouble reading are eligible to apply. Interested applicants must submit an abstract of their proposed projects (not to exceed 2 pages) and an NIH-style biosketch via email to Coordinator named above by no later than the internal deadline above for consideration. | | | | Read More | | |
| |
| | | | During this challenging time, Pfizer is committed to doing all we can to respond to the COVID-19 pandemic. We recognize the need for the rapid development of educational programs and trainings and the implementation of systemic best practices for COVID19 management. As part of our commitment, we are releasing this Request for Proposals (RFP) to provide financial support for organizations producing independent educational programs and quality improvement initiatives designed to combat this evolving crisis. | | | | Read More | | |
| |
| | | | Due to the disruption caused by the COVID-19 crisis, Emory SOM is postponing the deadline for Bridge Funding applications to May 15, 2020. In addition, we are adding two contingencies to this round: 1) The start date for Bridge awards will be dependent on the University research ramp-up timeline and 2) Bridge funding will be contingent on the SOM budget at the time of award. | | | | Read More | | |
| |
| | | | The Kidney Cancer Association is pleased to announce applications for both its Young Investigator Awards (YIAs) and Advanced Discovery Awards (ADAs). YIAs encourage promising researchers in urology and clinical oncology who are planning to pursue an investigative career in kidney cancer. A total of $1.3 million in funding will be available, four $75,000 YIAs and two $500,000 ADAs. | | | | Read More | | |
| |
| | | | The vision of the Peer Reviewed Medical Research Program is to improve the health, care, and well-being of all military Service members, Veterans, and beneficiaries, and its mission is to encourage, identify, select, and manage medical research projects of clear scientific merit and direct relevance to military health. Thus, the proposed research must be relevant to active duty Service members, Veterans, military beneficiaries, and/or the American public. The PRMRP challenges the scientific and clinical communities to address at least one of the FY20 PRMRP Topic Areas of Emerging Viral Diseases and Respiratory Health with original ideas that foster new directions along the entire spectrum of research and clinical care. | | | | Read More | | |
| |
| | | | This award is intended to support investigators with a stellar track record of accomplishment who have the potential to advance our knowledge of COVID-19 and other novel respiratory viruses with pandemic potential. Successful applicants are investigators with evidence of ongoing excellence and productivity in a related field. The award is for $100,000 per year, for up to two years. | | | | Read More | | |
| |
| | | | National Center for Advancing Translational Sciences (NCATS) is issuing this Notice of Special Interest to highlight the urgent need for research on the 2019 novel coronavirus and the disease it causes. NCATS is particularly interested in projects that repurpose existing drugs or biologics (existing therapeutics) that have already begun or completed a Phase I clinical trial. | | | | Read More | | |
| |
| | | | Pfizer Global Medical Grants support patient-focused programs that help patients and providers address the heightened medical and educational needs of patients with primary immunodeficiency during this pandemic. Priority will be awarded to projects that leverage the utilization of innovative technology platforms for distant learning to reach the intended audience with a focus on patient outreach, medical support and telework. | | | | Read More | | |
| |
| | | | AMAG Pharmaceuticals, Inc. is committed to funding research aimed at reducing the risk of premature birth and preeclampsia in order to improve the health of neonates and infants in the United States through its 2020 Prematurity and Preeclampsia Research Grants Program for a total of $250,000. Consideration will be given to basic or clinical research in maternal, fetal and neonatal/infant health. | | | | Read More | | |
| |
| | | | The purpose of this Notice of Special Interest is to highlight the list of widely appreciated systematic barriers or translational science problems included in PAR-19-099 and PAR-19-100 to add the following topics of interest: Rural Health, Racial and Ethnic Disparities in Maternal Mortality, Applications for Machine Learning and Artificial Intelligence (AI), Veterans' Health. | | | | Read More | | |
| |
| | | | The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) requests applications for the NIAMS Resource-based Centers Program (P30) for rheumatic diseases research areas within its mission. The Resource-based Centers will provide critical research infrastructure, shared facilities, services, and/or resources to groups of investigators conducting research on rheumatic diseases, enabling them to conduct their independently funded individual and/or collaborative research projects more efficiently and/or more effectively. Application budgets are limited to $500,000 direct costs per year. The maximum project period is 5 years. | | | | Read More | | |
| |
| | | | Calling All Mentees: The Georgia Clinical & Translational Science Alliance TEAMS (Translational Education and Mentoring in Science) Program is seeking junior-level faculty members, post-docs, or clinical fellows interested in receiving 1:1 and group mentoring. Apply now to be a Fellow! | | | | Apply Now! | | |
| |
| | | | The Georgia Clinical & Translational Science Alliance TEAMS (Translational Education and Mentoring for Science) Program is seeking learning community mentors, one-on-one mentors and content experts to participate in the 2020-2021 academic year program. Submit Interest Form by June 1. https://www.surveymonkey.com/r/TSDDV92 | | | | Read More | | |
| |
| | | | The new Georgia CTSA Grant Wise service offers the opportunity for one-on-one feedback from experienced senior faculty on grant writing. We are soliciting experienced faculty to serve as volunteer mentors. If you have experience in writing grants and you enjoy mentoring, we need you! After completing the online volunteer form, we will be in touch should we receive a request that matches your expertise. Contact lauren.james@emory.edu | | | | Volunteer Form | | |
| |
| | | | Are you pursuing a NIH award (K, R, SC, U), Diversity Supplement, or Pilot Grant? Apply to participate in NRMN’s Research Study. The importance of the study is to examine the effects of Early Stage Investigators (ESIs) characteristics, contextual factors, as well as institutional contexts that shape their social capital, research productivity, and career persistence. | | | | Read More | | |
| |
| | | | Many Emory investigators are pursuing essential and critical research projects focused on the COVID-19 pandemic. If you have plans to collect or are currently collecting samples from COVID-19 patients, please respond with a brief description of your work and the type of sample (DNA, serum, PBMCs) you need. Providing essential platforms to support COVID-19 research is a high priority. Requests for new equipment to directly support COVID-19 research are being collected via email. Please send email to Mike Zwick at mzwick@emory.edu. | | | | Read More | | |
| |
| | | | CURE ID is an internet-based repository that lets the clinical community report novel uses of existing drugs for difficult-to-treat infectious diseases through a website, a smartphone or other mobile device. The platform enables the crowdsourcing of medical information from health care providers to guide potentially life-saving interventions and facilitate the development of new treatments for neglected diseases. CURE ID is a collaboration between the FDA and the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH). | | | | Read More | | |
| |
| | | | We are a community of medical professionals, life scientists and data scientists on a quest to defeat COVID-19. To pitch in, join our discourse! | | | | Read More | | |
| |
| | | | The COVID-19 HPC Consortium encompasses computing capabilities from some of the most powerful and advanced computers in the world. We hope to empower researchers around the world to accelerate understanding of the COVID-19 virus and the development of treatments and vaccines to help address infections. Consortium members manage a range of computing capabilities that span from small clusters to some of the very largest supercomputers in the world. Learn more about how to request access to resources of the COVID-19 HPC Consortium. | | | | Read More | | |
| |
| | | | Georgia CTSA is now offering Virtual Studios to meet your research brainstorming needs. Our on-site presence has temporarily changed, but our desire to help you plan and collaborate regarding existing and potential research has not paused. Examples of areas where we have served past customers with expert brainstorming include locating collaborators and resources, hypothesis generation, study design, implementation, analysis and interpretation, translation and manuscript development of research topics. Contact the Georgia CTSA Coordinating Center by emailing Karen Lindsley at klindsl@emory.edu or Submit a Request for a Studio Consultation. | | | | Submit a Request | | |
| |
| | | | Allocating Credit: The Tyrannical Principal Investigator (PDF) | | | | Read More | | |
| |
| | | | Registration is now open for the SBIR Road Tour stopping at UGA in Athens, GA. National outreach effort connecting entrepreneurs working on advanced technologies to the country’s largest source of early stage funding – the SBIR/STTR programs. Opportunity for small businesses, innovators, researchers, entrepreneurs and technology companies to connect directly with SBIR/STTR program managers representing more than a dozen different federal agencies. SBIR/STTR programs provide over $3.7 billion in funding to small businesses each year in a wide variety of technology areas. | | | | Read More & Register | | |
| |
| |  | | The Georgia CTSA recently partnered with the All of Us Research Program. All of Us is a health research program funded by the National Institutes of Health (NIH). Its goal is to help researchers better understand why people get sick or stay healthy. The mission of the All of Us Research Program is simple: to speed up health research and medical breakthroughs. To do this, All of Us is asking one million people from across the U.S. to share their health ... | | | | Read More | | |
| |
| | | | Have a great biological target but no chemical probes? The Emory initiative on Biological Discovery through Chemical Innovation (BDCI) plans to host a brainstorming session via Zoom today, Friday, May 1st from 12:00 pm – 2:00 pm. Present and/or listen! We are especially interested in exploring new opportunities that bridge innovative ideas between biology and chemistry. | | | | Read More | | |
| |
| | | | Join us for a webinar lecture on "Pediatric Health Information System (PHIS) for Health Service Research", featuring Harold K. Simon, MD, MBA and Kiesha Fraser Doh, MD on May 1st from 12:00 PM – 1:00 PM. RSVP by April 30. | | | | Register | | |
| |
| | | | Spring 2020 NanoFANS (Focusing on Advanced Nanobio- Systems) program will be offered in a weekly webinar format during the month of May. The focus of this event will be “Nanotechnology in Infectious Diseases (Diagnostics/Therapeutics)." Infectious diseases are the leading cause of mortality worldwide, with viruses such as, Ebola, SARS-CoV, and SARS-CoV-2 making global impact on healthcare and socio-economic development. The application of nanotechnology in infectious diseases is fast-revolutionizing the biomedical field and the healthcare sector and has a potential to diagnose, treat and prevent diseases. | | | | Read More | | |
| |
| | | | Join researchers and clinicians from across the Georgia CTSA for a session via Zoom on Brain Health and COVID-19 on May 4th from 2:00 PM – 3:15 PM. Share your experience, learn from others, enjoy opportunities for interdisciplinary networking and find potential collaborators! RSVP to reserve your seat and receive Zoom link information. https://bit.ly/BrainHealth19 | | | | Read More | | |
| |
| | | | Join Advances in Research (AiR) for a webinar lecture on “YAP Regulates Tumor Growth, Therapy Response, and Survival Under Tumor Environmental Stress in Neuroblastoma” by Jenny Shim, MD on Tuesday, May 5th from 12:30 pm – 1:00 pm. | | | | Read More | | |
| |
| | | | Join us via Zoom on Thursday, May 14 from 1:00-2:00 P.M.to learn of and share experiences in community engaged research, clinical care, and practice as we adjust to uncertain times. The purpose of this webinar is to discuss how to develop and sustain community engagement approaches that positively impact population health while navigating a public health epidemic. | | | | Register | | |
| |
| | | | Join this free webinar from 11:30 am - 12:30 pm on May 19 to learn business strategies around equity negations, fundraising, and dilution for life science start-ups. Speaker, James Stubbs, PhD has over 20 years of commercialization experience and has held senior executive roles in five medical device startups including founder, CEO, CTO, CSO and VP Scientific Affairs. Since 2005 he has contributed to four successful startup exits valued at over $500M. James is currently teaching medical device design and Capstone in the Biomedical Engineering Department at Georgia Tech and is an active private investor. Please note all talks for the remainder of this series will be hosted via webinar. | | | | Register | | |
| |
| | | | Who can submit an abstract? All child health researchers who are postdocs, fellows and junior faculty with a rank of no higher than assistant professor are invited to submit abstracts as the lead author. Select abstracts will be invited to do oral presentations at the symposium on August 4th, 2020 at the Health Sciences Research Building Auditorium and Café. | | | | Read More | | |
| |
| | | | Thank you for your commitment to pediatric research and interest in attending the Southeastern Pediatric Research Conference. We have been closely monitoring the COVID-19 outbreak, and in an effort to keep everyone safe and healthy, we have made the difficult decision to cancel this event. During the time you had reserved to participate in the conference, we strongly encourage you to participate instead in a special three-hour COVID-19 webinar highlighting several current COVID-19-related research projects. The specific time and complete agenda will be announced here as soon as they are available. | | | | Read More | | |
| |
| For more information on Georgia Clinical & Translational Science Alliance (Georgia CTSA), please visit
www.GeorgiaCTSA.org. Do you have news, seminars, or events of interest to clinical and translational researchers? Send them to
GeorgiaCTSA@emory.edu by noon on Thursday. To suggest subscribers or unsubscribe to the listserv please email
GeorgiaCTSA@emory.edu.
Please include the following citation in any publications resulting from direct or indirect Georgia CTSA support, "Supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under Award Number UL1TR002378. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health." KL2 Scholars should also list KL2TR002381 and TL1 Trainees should also list TL1TR002382. |
| |
|
